Although cancer treatment is mostly as good here as elsewhere, access to treatment needs to be expedited. And if, for example, a new cancer drug has already been introduced in Sweden or Denmark, wouldn't it be better to utilize these experiences rather than starting the whole process from scratch ourselves? (translated)